Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy

BACKGROUND: Combined, platinum-based thoracic chemoradiotherapy (TCR) is the current state-of-the-art treatment for patients with limited disease (LD) small-cell lung cancer (SCLC). There is only limited data available regarding the effect of comorbidities on survival following TRC. The purpose of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fink, Christoph A., Weykamp, Fabian, Adeberg, Sebastian, Bozorgmehr, Farastuk, Christopoulos, Petros, Lang, Kristin, König, Laila, Hörner-Rieber, Juliane, Thomas, Michael, Steins, Martin, El-Shafie, Rami A., Rieken, Stefan, Bernhardt, Denise, Debus, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410177/
https://www.ncbi.nlm.nih.gov/pubmed/37564923
http://dx.doi.org/10.1016/j.ctro.2023.100665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410177/
https://www.ncbi.nlm.nih.gov/pubmed/37564923
http://dx.doi.org/10.1016/j.ctro.2023.100665

Ejemplares similares